Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors

Indications for current immune checkpoint inhibitors are expanding and now include thymic epithelial tumors (TETs). Although clinical trials on immune checkpoint inhibitors for TETs are ongoing, a rationale has not yet been established for immunotherapy for TETs. Therefore, we herein performed pheno...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Yamamoto, Yoko, Iwahori, Kota, Funaki, Soichiro, Matsumoto, Mitsunobu, Hirata, Michinari, Yoshida, Tetsuya, Kanzaki, Ryu, Kanou, Takashi, Ose, Naoko, Minami, Masato, Sato, Eiichi, Kumanogoh, Atsushi, Shintani, Yasushi, Okumura, Meinoshin, Wada, Hisashi
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055333/
https://ncbi.nlm.nih.gov/pubmed/32132638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-61053-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares